Skip to content

Clinical study of non-surgical treatment program for different stages of Lumbar disc herniation

Clinical study of non-surgical treatment program for different stages of Lumbar disc herniation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001343
Enrollment
Unknown
Registered
2011-05-20
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

Subacute inflammation group:(1) Shishi manipulation + (2) Lumbar Traction + (3) Chinese medicine for external plaster.+(4) Functional ExerciseIntervention duration for 14 days.
Acute inflammation group:(1) Single Point of deep acupuncture needling+(2) Lumbar Traction+(3) Dehydrating agent+(4) Chinese medicine for external plaster.Intervention duration for 14 days.
Chronic adhesion group:(1) Use manipulation to relax at epidural anesthesia condition+(2) IIntravenous injection of Chinese herb of improving blood circulation.+(3) Physical Therapy.+(4) Chinese medic
Standard conservative treatment group:Regularly to the clinic the patients of lumbar disc herniation receive health education, mainly to introduce the disease in patients with the natural process and

Sponsors

Shanghai ShuGuang Hospital Affiliated to Shanghai University of T.C.M
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 20 to 60 years old, male or female; 2. Mainly leg pain, leg pain was typical of the sciatic nerve distribution; 3. Distribution area of the skin along the nerve sensory dysfunction; 4. neurological signs appeared in two of four signs (muscle atrophy, motor weakness, sensory loss and less radiation); 5. voluntarily joined the trial, and signed "informed consent".

Exclusion criteria

Exclusion criteria: 1. history of spinal surgery; 2. severe spinal trauma; 3. imaging findings with spinal bone tumor, tuberculosis, osteoporosis and other patients; 4. with cardiovascular, cerebrovascular, blood, digestive system and other seriousdisease or mental illness; 5. pregnant and lactating women; 6. liver and kidney dysfunction; 7. other autoimmune diseases, allergic diseases and acute or chronic infection; 8. reluctant to join the trials.

Design outcomes

Primary

MeasureTime frame
Oswestry disabilityindex, ODI;SF-36;

Countries

China

Contacts

Public ContactHongsheng Zhan
shgsyjs@139.com+86 13918449223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026